Article Rich – Lifestyle
Author:
RZNOMICS INC.
Rznomics Announces U.S. FDA Regenerative Medicine Advanced Therapy Designation Granted to ‘RZ-001’ for Hepatocellular Carcinoma
May 8, 2026
Rznomics Reports Interim Clinical Data for RZ-001 in Hepatocellular Carcinoma at AACR 2026 Demonstrating Encouraging Efficacy and Favorable Safety Profile
April 20, 2026